Australia markets open in 8 hours 22 minutes

Sana Biotechnology, Inc. (SANA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.73+0.18 (+2.11%)
At close: 04:00PM EDT
8.96 +0.23 (+2.63%)
After hours: 06:19PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-299,764
-283,255
-269,476
-355,928
-285,305
Depreciation & amortisation
14,765
24,557
15,625
11,070
5,921
Deferred income taxes
-
-
-
0
0
Stock-based compensation
35,059
35,533
38,337
22,362
5,828
Change in working capital
11,593
18,611
7,542
9,801
6,156
Accounts payable
481
1,027
1,058
-266
1,982
Other working capital
-345,558
-273,614
-310,926
-280,916
-161,854
Other non-cash items
-85,735
-49,028
-82,078
61,641
129,418
Net cash provided by operating activities
-324,082
-253,582
-290,050
-251,054
-137,982
Cash flows from investing activities
Investments in property, plant and equipment
-21,476
-20,032
-20,876
-29,862
-23,872
Acquisitions, net
-
-
-
0
0
Purchases of investments
-140,533
-157,744
-78,688
-491,387
-387,432
Sales/maturities of investments
215,056
349,788
310,126
280,025
158,741
Other investing activities
-
-
-
-4,574
-
Net cash used for investing activities
48,473
172,012
210,562
-245,798
-252,563
Cash flows from financing activities
Common stock issued
724
31,646
4,913
631,751
0
Net cash used provided by (used for) financing activities
6,971
31,646
4,913
631,751
435,687
Net change in cash
-268,638
-49,924
-74,575
134,899
45,142
Cash at beginning of period
442,489
187,273
261,848
126,949
81,807
Cash at end of period
173,851
137,349
187,273
261,848
126,949
Free cash flow
Operating cash flow
-324,082
-253,582
-290,050
-251,054
-137,982
Capital expenditure
-21,476
-20,032
-20,876
-29,862
-23,872
Free cash flow
-345,558
-273,614
-310,926
-280,916
-161,854